Table 2.
Clinical and laboratorial characteristics in T2D patients considering nephropathy (DNP).
| Variables | Diabetic nephropathy | ||
|---|---|---|---|
| Yes (n = 80) | No (n = 20) | p | |
| Age (years) | 58.00 (13.00) | 50.50 (9.00) | <0.0001∗ |
| Gender (male/female) % | 21.25/78.75 | 10.00/90.00 | 0.348 |
| BMI (Kg/m2) | 30.48 ± 6.06 | 40.55 ± 5.23 | <0.0001∗ |
| Hypertension (yes/ no) % | 90.00/10.00 | 100.00/0 | 0.204 |
| Dyslipidemia (yes/no) % | 96.25/3.75 | 85.00/15.00 | 0.092 |
| Fasting glucose (mg/dL) | 143.00 (97.50) | 117.00 (55.50) | 0.027∗ |
| Postprandial glucose (mg/dL) | 214.00 (107.50) | 144.50 (122.25) | 0.045∗ |
| HbA1c % | 9.24 ± 1.88 | 7.73 ± 1.84 | 0.006∗ |
| T2D onset (years) % | |||
| ≤5 | 11.54b | 47.37 | 0.001∗ |
| 5–10 | 14.10 | 15.79 | |
| ≥10 | 74.36a | 36.84 | |
BMI: body mass index and HbA1c: glycated hemoglobin.
Normal variables (BMI and HbA1c): the data are shown as mean ± standard deviation.
No normal variables (age, fasting glucose, and postprandial glucose): the data are shown as median (interquartile range).
Categorical variables (gender, hypertension, dyslipidemia, and T2D onset): the data are shown as “percentage of total.”
∗ p < 0.05 was considered statistically significant.
aMore frequent; bless frequent, residual analysis.